Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02528539 · ClinicalTrials.gov registry record · NA
Prevention of Lymphedema Among Breast Cancer Patients Through Implementation of an Integrative Therapy Program (ITP)
A NA study, sponsored by Huntington Memorial Hospital.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02528539 is a NA study that has completed, run by Huntington Memorial Hospital. The registered enrollment target is 10 participants.
The verdict
NCT02528539, a NA study, has completed, sponsored by Huntington Memorial Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Introduction: Breast cancer women who are treated with axillary node dissection are at increased risk for lymphedema - the lifetime risk in these women is estimated at 15-50% and the risk can significantly increase with chemotherapy and radiation therapy Objectives: 1. To evaluate the feasibility and effectiveness of implementing the integrative therapy program (ITP) intervention. ITP consists of self-management education in conjunction with acupuncture. 2. To determine if ITP affects quality of life, self-efficacy, lymphedema knowledge, pain, and early detection and management of lymphedema. Design: the exploratory study aims to evaluate the feasibility and benefits of the integrative therapy program (ITP) intervention post-operatively for 18 months. Subjects: Women with breast cancer treated with axillary node dissection with normal baseline pre-operative bioimpedance (L-dex U400) score. Sample size: 30 subjects
Interventions
- OTHER ITP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02528539
The ClinicalTrials.gov registry entry for NCT02528539 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Huntington Memorial Hospital, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ITP is the first listed.
NCT02528539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02528539 about?
NCT02528539 is a clinical study titled "Prevention of Lymphedema Among Breast Cancer Patients Through Implementation of an Integrative Therapy Program (ITP)". Introduction: Breast cancer women who are treated with axillary node dissection are at increased risk for lymphedema - the lifetime risk in these women is estimated at 15-50% and the risk can significantly increase with chemotherapy and radiation therapy Objectives: 1. To evaluate the feasibility ...
What is the current status of trial NCT02528539?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2013-08. Estimated completion is 2016-12-30.
What interventions are being tested in trial NCT02528539?
The interventions under investigation include: ITP (OTHER).
Who is sponsoring clinical trial NCT02528539?
This trial is sponsored by Huntington Memorial Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.